Biopharming
  • strict warning: Declaration of views_handler_filter_node_status::operator_form() should be compatible with views_handler_filter::operator_form(&$form, &$form_state) in /home/nwrageadmin/d6.nwrage.org/sites/all/modules/views/modules/node/views_handler_filter_node_status.inc on line 13.
  • strict warning: Declaration of views_plugin_style_default::options() should be compatible with views_object::options() in /home/nwrageadmin/d6.nwrage.org/sites/all/modules/views/plugins/views_plugin_style_default.inc on line 24.

Europe Rejects Genetically Engineered Drug

Biopharming

By ANDREW POLLACK February 24, 2006

New York Times

European regulators declined yesterday to approve what would have been
the first drug produced in the milk of genetically engineered animals,
dealing a setback to a fledgling industry that aims to convert cows,
goats and rabbits into low-cost pharmaceutical factories.

The decision was closely watched because companies developing
drug-producing animals need an approval from either the United States or

LSBC closing signals pharming trouble

Biopharming

Fall of pioneer in using transgenic plants for pharmaceuticals has analysts worried field may dry up

By Ted Agres The Scientist
[Published 17th January 2006 05:42 PM GMT]

Company engineers safflower plants for insulin

Biopharming

=====================================================================================
Company engineers safflower plants for insulin

SOURCE: Canadian Broadcasting Corporation
http://www.cbc.ca/story/science/national/2005/12/28/insulin-
safflower051228.html
DATE: 29 Dec 2005

Safflower, a plant used as cooking oil, is being tested by a Canadian
company to determine if it can make a safe, pure and cheaper form of =
insulin.

Preliminary tests by scientists at SemBioSys of Calgary suggest it's
possible to use the plant as an insulin factory.

Biotech Company Closes After Running Out of Cash

Biopharming

===============================================================================================
Biotech Company Closes After Running Out of Cash

Date: December 24, 2005 4:42:35 PM EST
By ANDREW POLLACK

New York Times

In a setback for a controversial area of biotechnology, the company that
led the way in trying to produce pharmaceuticals in genetically modified
crops ran out of money and shut its doors yesterday.

The company, the Large Scale Biology Corporation, based in Vacaville,
Calif., said in a statement Thursday that all of its approximately 70

Report blasts oversight of pharmaceutical test fields

Biopharming

============================================================================================
Report blasts oversight of test fields

Investigators say the USDA lacks details on what happens with pharma-crops.

Published December 30, 2005

By PHILIP BRASHER
REGISTER WASHINGTON BUREAU

Washington, D.C. - The U.S. Department of Agriculture has failed to properly
oversee field trials of genetically engineered crops, including plants
designed to produce chemicals for medical and industrial uses, investigators
say.

Syndicate content